Clinical Trials Logo

Clinical Trial Summary

Treatment of patients with systemic sclerosis with autologous regulatory Т-cells


Clinical Trial Description

Considering the fact that a decrease in the content and functional activity of T-reg plays an important role in the immunopathogenesis of many systemic diseases of the connective tissue, the use of a large amount of T-reg can have a therapeutic effect. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05214014
Study type Interventional
Source Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Contact Andrei Hancharou, Dr
Phone +375296248972
Email [email protected]
Status Not yet recruiting
Phase Phase 1/Phase 2
Start date March 1, 2022
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Completed NCT03274076 - Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc) Phase 1/Phase 2
Recruiting NCT04300426 - Safety and Efficacy of Anaerobic Cultivated Human Intestinal Microbiome Transplantation in Systemic Sclerosis (ReSScue) Phase 2
Recruiting NCT04356755 - Subcutaneous Injections of Autologous ASC to Heal Digital Ulcers in Patients With Scleroderma. Phase 2
Recruiting NCT02551042 - CSL Behring Sclero XIII Phase 2
Terminated NCT02246348 - Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc) N/A
Terminated NCT02243111 - Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by Ultrasound N/A
Completed NCT01933334 - Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS) Phase 2
Completed NCT01468792 - Hemodynamic Changes in Connective Tissue Disease N/A
Terminated NCT00848107 - Open-Label Study of Oral Treprostinil in Digital Ulcers Phase 2
Completed NCT00984932 - Effect of Rosuvastatin on Systemic Sclerosis-related Pulmonary Hypertension Phase 3
Recruiting NCT00074568 - Scleroderma Registry
Terminated NCT00622687 - Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis Phase 2
Recruiting NCT04464434 - Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis Phase 3
Recruiting NCT04246528 - SPIN Self-Management Feasibility Trial With Progression to Full-scale Trial (SPIN-SELF) N/A
Completed NCT03678987 - Mycophenolate Mofetil Pharmacokinetics in Systemic Sclerosis
Recruiting NCT05234671 - Exercise in People With Systemic Sclerosis N/A
Not yet recruiting NCT04971018 - Impact of Transcutaneous Auricular Vagus Nerve Stimulation on Digestive Symptoms in Systemic Sclerosis Systemic Sclerosis N/A
Recruiting NCT04132206 - Longitudinal Characterization of Microbial Signature in Systemic Sclerosis Patients
Recruiting NCT03211793 - Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis Phase 1/Phase 2
Recruiting NCT03374618 - Neutrophil Extracellular Traps in Systemic Sclerosis N/A